Effect of chronic low dose of methotrexate on cellular proliferation during spermatogenesis in rats

A K Saxena1, S Dhungel, S Bhattacharya

  • 1Human Cytogenetics Laboratory, Department of Anatomy, B.P. Koirala Institute of Health Sciences, Dharan-Nepal. draksaxena1@rediffmail.com

Archives of Andrology
|December 9, 2003
PubMed

Insights

Methotrexate exposure significantly damages male rat testes, reducing seminiferous tubule diameter and altering germ cell size. This study reveals methotrexate

Area of Science:

  • Reproductive toxicology
  • Spermatogenesis research
  • Cellular biology

Background:

  • Methotrexate is a chemotherapy agent with known reproductive side effects.
  • Understanding its impact on testicular cellular proliferation is crucial for managing treatment toxicity.

Purpose of the Study:

  • To evaluate the effects of continuous methotrexate exposure on germinal and non-germinal elements in rat seminiferous tubules.
  • To elucidate the mechanism of methotrexate-induced testicular damage during spermatogenesis.

Main Methods:

  • Male rats were exposed to methotrexate (12.5 microgram) continuously from Day 1 to Day 17.
  • Cellular proliferation and morphological changes in seminiferous tubules were assessed and compared to control groups.

Main Results:

  • Significant decrease in seminiferous tubule diameter and increased interstitial space observed.
  • Altered size of primary, secondary spermatocytes, and spermatids; vacuolization/decondensation of chromatin-mass in spermatocytes.
  • Reduced Sertoli and Leydig cell size; disrupted and thinned basement membrane noted.

Conclusions:

  • Methotrexate induces cytotoxicity affecting cellular proliferation within seminiferous tubules.
  • The study elucidates a dose-dependent mechanism for drug-induced testicular damage during spermatogenesis.